Skip to content

Sequence optimization and technology standardization of liver high field MRI examination

Sequence optimization and technology standardization of liver high field MRI examination

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-11001587
Enrollment
Unknown
Registered
2011-08-23
Start date
2010-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases

Interventions

Gold Standard:
Index test:

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Focal lesions difficult to diagnose or solid lesions of liver found or suspected by Ultrasound, CT or other inspection methods; 2. High-risk groups of HCC: patients with hepatitis b or hepatitis c virus, over 40 years old, liver dysfunction or with high level of AFP; 3. Patients with malignant tumor, suspected liver metastases. Patients with one of the above standards can enter our group. Each patient should sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. With severe organ failure; 3. With moderate to severe kidney damage, defined as GFR/eGFR<60mL/min; 4. Equipped with pacemakers, artificial heart valves or other implants that can't be close to the strong magnetic field; 5. Severe claustrophobic patients; 6. Patients who don’t cooperate; 7. (1)lesions bigger than 5 cm (2)with more than 5 lesions of the same type and some fuse; 8. Have received operation or intervention before the test.

Design outcomes

Primary

MeasureTime frame
SNR, contrast noise ratio and artifacts;

Countries

China

Contacts

Public ContactZhenghan Yang
zhenghanyang@263.net+86 10 85133819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026